BLOOD CULTURE
AS AN IMPORTANT DIAGNOSTIC
TOOL IN MEDICAL MICROBIOLOGY
BY
OSAYANDE CHELSEA IMUETINYANOSA
A SEMINAR PRESENTATION IN PARTIAL FULFILMENT FOR INTERNSHIP
IN MEDICAL MICROBIOLOGY, NATIONAL HOSPITAL ABUJA.
SEMINAR SUPERVISOR: SCT. NDIKE U.P. (PMLS)
CO-ORDINATOR: SCT. AKHIGBE ALEX (CMLS)
13TH JANUARY, 2023
OUTLINE
INTRODUCTION
DEFINITION OF TERMS
WHAT IS BLOOD CULTURE
HISTORY
SAMPLE COLLECTION
LABORATORY ANALYSIS
INSTRUMENTATION
QUALITY CONTROL
CONCLUSION
RECOMMENDATION
REFERENCES
INTRODUCTION
One of the most important functions of the clinical microbiology laboratory is the
detection and characterization of organisms causing bloodstream infections
(Gonzalez et al., 2020).
The laboratory detection of bacteremia and fungemia using blood cultures is one of
the most
simple and commonly used investigations to establish the etiology of bloodstream
infections.
Rapid, accurate identification of the bacteria or fungi causing bloodstream infections
provides vital clinical information required to diagnose and treat sepsis (CLSI
document M47-A, 2007). `
DEFINITION OF TERMS
Bacteremia
• The presence of bacteria in the blood. It may be transient,
intermittent or continuous. he presence of bacteria in the
blood. It may be transient, intermittent or continuous
Fungemia:
• The presence of fungi in the blood
Septicemia:
• Clinical syndrome characterized by fever, chills, malaise,
tachycardia, etc. when circulating bacteria multiply at a rate
that exceeds removal by phagocytosis
(Singer et al., 2016).
WHAT IS A BLOOD CULTURE?
A blood culture is a laboratory test in which blood, taken from the patient, is inoculated
into bottles containing culture media to determine whether infection-causing
microorganisms (bacteria or fungi) are present in the patient’s bloodstream (Singer et
al., 2016).
Blood cultures are intended to:
Confirm the presence of microorganisms in the bloodstream
 Identify the microbial etiology of the bloodstream infection
Help determine the source of infection (e.g., endocarditis)
Provide an organism for susceptibility testing and optimization of antimicrobial therapy
(Singer et al., 2016).
HISTORY
Manualithic
(pre-1970)
• Dr. Jean Antoine
Villemin déveloped
biological blood
culture
• recognition of
“Liquoid” as a
potent anticoagulant
Bactecene
(1970 to 1990
• Automated blood
culture systems first
became available in
the 1970s
• 1984 a new
generation of
BACTEC
instruments was
released that
used spectrophoto
metry to detect
CO2.[
Continuous
Monitorassic
(1990 to 2000)
• BacT/Alert
colorimetric
microbial detection
system in 1990
• Bactec 9000 series
• ESP
Ampliaissance
(post-2000) ages
• Molecular based
assays or high-
resolution
spectrometry
• Increase speed of
detection
(Ombelet et al., 2019)
WHEN SHOULD A BLOOD CULTURE BE PERFORMED?
Blood cultures should always be requested when a bloodstream infection or sepsis is
suspected.
Clinical symptoms in a patient which may lead to a suspicion of a bloodstream
infection are:
undetermined fever (≥38°C) or hypothermia (≤36°C)
shock, chills, rigors
severe local infections (meningitis, endocarditis, pneumonia, pyelonephritis, intra-
abdominal suppuration).
abnormally raised heart rate
low or raised blood pressure
raised respiratory rate
Baron (et al., 2005).
SAMPLE COLLECTION
BLOOD CULTURE MEDIUM
FIGURE 8 | Dissection of blood culture bottle (Ombelet et al., 2019).
MEDIA FORMULATIONS
 Base :
soybean casein digest (trypticase soy broth)
supplemented peptone broth
brain heart infusion broth
Anticoagulant :
sodium polyanethol sulfonate (SPS)
Headspace Atmoshere:
CO2 and N2 for anaerobic bottles and ambient
air supplemented with CO2 for aerobic bottles
Additives
Reducing agent
Polymeric resin beads
Yeast extract
(Gross et al., 2018).
PREVENTING CONTAMINATION OF BLOOD CULTURES
Disinfect Skin sites for collection with an
alcohol containing disinfectant.
blood should not be collected from an
intravascular device
use of commercial diversion devices
(Doern et al., 2019).
Figure: steripath gen2 initial specimen
diversion device
ORDER OF DRAW
If using a winged blood collection set, then the
aerobic bottle should be filled first to prevent transfer
of air in the device into the anaerobic bottle.
If using a needle and syringe, inoculate the
anaerobic bottle first to avoid entry of air.
If the amount of blood drawn is less than the
recommended volume*, then approximately 10 ml of
blood should be inoculated into the aerobic bottle
first, since most cases of bacteremia are caused by
aerobic and facultative bacteria (Ombelet et al.,
2019).
WHAT VOLUME OF BLOOD SHOULD BE COLLECTED?
The American Society for Microbiology (ASM) and the Infectious Diseases Society of
America (IDSA) jointly recommend 2 to 4 collections per septic episode.
 Blood culture bottles are designed to accommodate the recommended blood- to-
broth ratio (1:5 to 1:10) with optimal blood volume.
ADULTS
for adults, 40 to 60 ml of blood collected from the patient for the 4 to 6 bottles, with 10
ml per bottle.
PEDIATRIC
The optimal volume of blood to be obtained from infants and children is less well
prescribed. The recommended volume of blood to collect should be based on the
weight of the patient (Mosta et al., 2017).
Weight of
patient
Patient’s total
blood volume
(ml)
Recommended
volume of blood
for culture (ml)
Total volume
for culture (ml
)
% of patient’s
total blood
volume
kg Ib Culture
no.1
Culture
no.2
≤1 ≤2.2 50-99 2 2 4
1.1-2 2.2-4.4 100-200 2 2 4 4
2.1-12.
7
4.5-27 >200 4 2 6 3
12.8-3
6.3
28-80 >800 10 10 20 2.5
>36.3 >80 >2,200 20-30 20-30 40-60 1.8-2.7
Table 1: Blood volumes suggested for cultures from infants and children
(Kellog el al., 2000).
LABORATORY ANALYSIS
BLOOD CULTURE SYSTEMS
INCUBATION
PROCESSING POSITIVE BLOOD CULTURE
INSTRUMENTATION
CONTAMINANT OR TRUE PATHOGEN
QUALITY CONTROL
BLOOD CULTURE SYSTEMS
MANUAL SYSTEMS
The bottles are visually examined for indicators of microbial growth, which might
include cloudiness, the production of gas, the presence of visible microbial
colonies, or a change in colour from the digestion of blood, which is
called hemolysis.
Conventional broth based system
Biphasic systems such as hemoline and septi-check system
Displacement (signal) system
 lysis centrifugation (isolator) system to culture blood for molds and mycobacteria.
(Mosta et al., 2017).
Figure: Signs of growth in blood culture bottles. (A) pellicle formation on surface; (B) gas
production; (C) turbidity (left bottle: no growth; right bottle: turbidity); (D) puff balls (Ombelet
et al., 2019).
BLOOD CULTURE SYSTEMS contd
CONTINUOUS-MONITORING BLOOD CULTURE SYSTEM (CMBCS).
BacT/ALERT
Colorimetric change (at the bottom of the bottle) caused by drop in pH from
increased CO2 levels
BACTEC
Change in fluorescence caused by a drop in pH from increased CO2 levels
VersaTREK
Measures pressure changes caused by gas consumption or production (Doern et
al., 2019).
INSTRUMENTATION
Figure: BacT/ALERT, BACTEC, VersaTREK (Singer et al., 2016).
Figure : Clinically significant isolates per day demonstrating recommended days of incubati
on (Bourbeau and Foltzer , 2005).
PROCESSING POSITIVE BLOOD CULTURES
STAINING METHODS
• Gram stain
• Acridien orange
IDENTIFICATION
• subculture
• Molecular testing
• Mass spectrometry
MALDI-TOF MS),
DIRECT
IDENTIFICATION
• Accelerate phenotest
BC kit
• BD phoenix and
biome ́rieux VITEK2
systems
• Rapid AST (RAST)
method based on
direct disk diffusion
(ddd) testing
• Enzyme-based
targeted AST
(Singer et al., 2016).
CLINICAL EVIDENCE OF BACTERIAL INFECTION IS PRESENT
features of SSTI, urosepsis, pneumonia, SIRS criteria).
Detection of the same pathogen in blood culture sets from different venipuncture
sites
Pathogens that rarely indicate contamination:
oS. aureus
oS. pneumoniae
oS. pyogenes
oEnterobacteriaceae spp. including E. coli
oH. influenzae
oP. aeruginosa
oCandida spp
oListeria monocytogenes
oNeisseria meningitidis
oAnaerobic Gram-negative rods
(Doern et al., 2019).
Figure: bacteria and yeast cells (Hall and Lyman, 2006).
CONTAMINANT OR A TRUE PATHOGEN?
A false positive is defined as growth of bacteria in the blood culture bottle that were
not present in the patient’s bloodstream, and were most likely introduced during
sample collection.
Contamination can come from a number of sources:
The patient’s skin,
The equipment used to take the sample,
The hands of the person taking the blood sample, or
The environment.
Certain microorganisms such as coagulase-negative staphylococci, viridans- group
streptococci, Bacillus spp, Propionibacterium spp., diphtheroids, Micrococcus spp.
rarely cause severe bacterial infections or bloodstream infections. These are common
skin contaminants (Hall and Lyman, 2006).
NEGATIVE BLOOD CULTURE
Before ruling out bacteremia, consider the following steps:
Determine whether it is likely the result could be a false-negative
Consider if:
Collection performed during current antibiotic treatment
Insufficient inoculation
 volume of each blood culture
Prolonged transportation time
Assess whether the pathogen identified is a plausible cause of the presenting
infection.If necessary, arrange for new blood culture sampling and analysis (Doern et
al., 2019).
CONCLUSION
Blood cultures allow the identification of pathogens, such as bacteria and fungi, in
blood and their specific resistance testing. Knowing the pathogen enables effective,
individualized antibiotic treatment, which reduces mortality, improves prognosis,
minimizes the length of hospital stays, and reduces the growing number of antibiotic-
resistant pathogens
REFERENCES
 Baron EJ, Weinstein MP, Dunne Jr. WM, Yagupsky P, Welch DF, Wilson DM. Cumitech 1C,
Blood Cultures IV. Coordinating ed., E.J. Baron. ASM Press, Washington D.C. 2005.
Bourbeau PP, Foltzer M. Routine incubation of BACT/ALERT* FA and FN blood culture bottles
for more than 3 days may not be necessary. J Clin Microbiol. 2005;43:2506-250
Doern GV, Carroll KC, Diekema DJ, et al. A comprehensive update on the problem of blood
culture contamination and a discussion of methods for addressing the problem. Clin Microbiol
Rev 2019;33(1). e00009-19
Doern GV, Carroll KC, Diekema DJ, et al. Practical Guidance for Clinical Microbiology
Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a
Discussion of Methods for Addressing the Problem. Clin Microbiol Rev. 2019; 33
(1). doi: 10.1128/cmr.00009-19
Gonzalez, M. D., Chao, T., & Pettengill, M. A. (2020). Modern Blood Culture. Clinics in
Laboratory Medicine. doi:10.1016/j.cll.2020.07.001
Hall KK, Lyman JA. Updated Review of Blood Culture Contamination. Clin Microbiol Rev.
2006,19(4):788.
REFERENCES
https://www.slideshare.net/MostafaMahmoud76/manual-blood-culture-techniques
Kellog JA, Manzella JP, Bankert DA. Frequency of low-level bacteremia in children from birth
to fifteen years of age.J Clin Microbiol. 2000;38:2181-2185.
Ombelet S, Barbé B, Affolabi D, Ronat J-B, Lompo P, Lunguya O, Jacobs J and Hardy L
(2019) Best Practices of Blood Cultures in Lowand Middle-Income Countries. Front. Med.
6:131. doi: 10.3389/fmed.2019.00131
Principles and procedures for Blood Cultures; Approved Guideline, CLSI document M47-A.
Clinical and Laboratory Standards Institute (CLSI); Wayne, P.A. 2007
Singer M, Deutschmann CS, Seymour CW, et al. The Third International Consensus
Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Singer M, Deutschmann CS, Seymour CW, et al. The Third International Consensus
Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Thank You For
Listening

BLOOD CULTURE AS AN IMPORTANT DIAGNOSTIC TOOL IN MEDICAL MICROBIOLOGY

  • 1.
    BLOOD CULTURE AS ANIMPORTANT DIAGNOSTIC TOOL IN MEDICAL MICROBIOLOGY BY OSAYANDE CHELSEA IMUETINYANOSA A SEMINAR PRESENTATION IN PARTIAL FULFILMENT FOR INTERNSHIP IN MEDICAL MICROBIOLOGY, NATIONAL HOSPITAL ABUJA. SEMINAR SUPERVISOR: SCT. NDIKE U.P. (PMLS) CO-ORDINATOR: SCT. AKHIGBE ALEX (CMLS) 13TH JANUARY, 2023
  • 2.
    OUTLINE INTRODUCTION DEFINITION OF TERMS WHATIS BLOOD CULTURE HISTORY SAMPLE COLLECTION LABORATORY ANALYSIS INSTRUMENTATION QUALITY CONTROL CONCLUSION RECOMMENDATION REFERENCES
  • 3.
    INTRODUCTION One of themost important functions of the clinical microbiology laboratory is the detection and characterization of organisms causing bloodstream infections (Gonzalez et al., 2020). The laboratory detection of bacteremia and fungemia using blood cultures is one of the most simple and commonly used investigations to establish the etiology of bloodstream infections. Rapid, accurate identification of the bacteria or fungi causing bloodstream infections provides vital clinical information required to diagnose and treat sepsis (CLSI document M47-A, 2007). `
  • 4.
    DEFINITION OF TERMS Bacteremia •The presence of bacteria in the blood. It may be transient, intermittent or continuous. he presence of bacteria in the blood. It may be transient, intermittent or continuous Fungemia: • The presence of fungi in the blood Septicemia: • Clinical syndrome characterized by fever, chills, malaise, tachycardia, etc. when circulating bacteria multiply at a rate that exceeds removal by phagocytosis (Singer et al., 2016).
  • 5.
    WHAT IS ABLOOD CULTURE? A blood culture is a laboratory test in which blood, taken from the patient, is inoculated into bottles containing culture media to determine whether infection-causing microorganisms (bacteria or fungi) are present in the patient’s bloodstream (Singer et al., 2016). Blood cultures are intended to: Confirm the presence of microorganisms in the bloodstream  Identify the microbial etiology of the bloodstream infection Help determine the source of infection (e.g., endocarditis) Provide an organism for susceptibility testing and optimization of antimicrobial therapy (Singer et al., 2016).
  • 6.
    HISTORY Manualithic (pre-1970) • Dr. JeanAntoine Villemin déveloped biological blood culture • recognition of “Liquoid” as a potent anticoagulant Bactecene (1970 to 1990 • Automated blood culture systems first became available in the 1970s • 1984 a new generation of BACTEC instruments was released that used spectrophoto metry to detect CO2.[ Continuous Monitorassic (1990 to 2000) • BacT/Alert colorimetric microbial detection system in 1990 • Bactec 9000 series • ESP Ampliaissance (post-2000) ages • Molecular based assays or high- resolution spectrometry • Increase speed of detection (Ombelet et al., 2019)
  • 7.
    WHEN SHOULD ABLOOD CULTURE BE PERFORMED? Blood cultures should always be requested when a bloodstream infection or sepsis is suspected. Clinical symptoms in a patient which may lead to a suspicion of a bloodstream infection are: undetermined fever (≥38°C) or hypothermia (≤36°C) shock, chills, rigors severe local infections (meningitis, endocarditis, pneumonia, pyelonephritis, intra- abdominal suppuration). abnormally raised heart rate low or raised blood pressure raised respiratory rate Baron (et al., 2005).
  • 8.
  • 9.
    BLOOD CULTURE MEDIUM FIGURE8 | Dissection of blood culture bottle (Ombelet et al., 2019).
  • 10.
    MEDIA FORMULATIONS  Base: soybean casein digest (trypticase soy broth) supplemented peptone broth brain heart infusion broth Anticoagulant : sodium polyanethol sulfonate (SPS) Headspace Atmoshere: CO2 and N2 for anaerobic bottles and ambient air supplemented with CO2 for aerobic bottles Additives Reducing agent Polymeric resin beads Yeast extract (Gross et al., 2018).
  • 11.
    PREVENTING CONTAMINATION OFBLOOD CULTURES Disinfect Skin sites for collection with an alcohol containing disinfectant. blood should not be collected from an intravascular device use of commercial diversion devices (Doern et al., 2019). Figure: steripath gen2 initial specimen diversion device
  • 12.
    ORDER OF DRAW Ifusing a winged blood collection set, then the aerobic bottle should be filled first to prevent transfer of air in the device into the anaerobic bottle. If using a needle and syringe, inoculate the anaerobic bottle first to avoid entry of air. If the amount of blood drawn is less than the recommended volume*, then approximately 10 ml of blood should be inoculated into the aerobic bottle first, since most cases of bacteremia are caused by aerobic and facultative bacteria (Ombelet et al., 2019).
  • 13.
    WHAT VOLUME OFBLOOD SHOULD BE COLLECTED? The American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA) jointly recommend 2 to 4 collections per septic episode.  Blood culture bottles are designed to accommodate the recommended blood- to- broth ratio (1:5 to 1:10) with optimal blood volume. ADULTS for adults, 40 to 60 ml of blood collected from the patient for the 4 to 6 bottles, with 10 ml per bottle. PEDIATRIC The optimal volume of blood to be obtained from infants and children is less well prescribed. The recommended volume of blood to collect should be based on the weight of the patient (Mosta et al., 2017).
  • 14.
    Weight of patient Patient’s total bloodvolume (ml) Recommended volume of blood for culture (ml) Total volume for culture (ml ) % of patient’s total blood volume kg Ib Culture no.1 Culture no.2 ≤1 ≤2.2 50-99 2 2 4 1.1-2 2.2-4.4 100-200 2 2 4 4 2.1-12. 7 4.5-27 >200 4 2 6 3 12.8-3 6.3 28-80 >800 10 10 20 2.5 >36.3 >80 >2,200 20-30 20-30 40-60 1.8-2.7 Table 1: Blood volumes suggested for cultures from infants and children (Kellog el al., 2000).
  • 15.
    LABORATORY ANALYSIS BLOOD CULTURESYSTEMS INCUBATION PROCESSING POSITIVE BLOOD CULTURE INSTRUMENTATION CONTAMINANT OR TRUE PATHOGEN QUALITY CONTROL
  • 16.
    BLOOD CULTURE SYSTEMS MANUALSYSTEMS The bottles are visually examined for indicators of microbial growth, which might include cloudiness, the production of gas, the presence of visible microbial colonies, or a change in colour from the digestion of blood, which is called hemolysis. Conventional broth based system Biphasic systems such as hemoline and septi-check system Displacement (signal) system  lysis centrifugation (isolator) system to culture blood for molds and mycobacteria. (Mosta et al., 2017).
  • 17.
    Figure: Signs ofgrowth in blood culture bottles. (A) pellicle formation on surface; (B) gas production; (C) turbidity (left bottle: no growth; right bottle: turbidity); (D) puff balls (Ombelet et al., 2019).
  • 18.
    BLOOD CULTURE SYSTEMScontd CONTINUOUS-MONITORING BLOOD CULTURE SYSTEM (CMBCS). BacT/ALERT Colorimetric change (at the bottom of the bottle) caused by drop in pH from increased CO2 levels BACTEC Change in fluorescence caused by a drop in pH from increased CO2 levels VersaTREK Measures pressure changes caused by gas consumption or production (Doern et al., 2019).
  • 19.
    INSTRUMENTATION Figure: BacT/ALERT, BACTEC,VersaTREK (Singer et al., 2016).
  • 20.
    Figure : Clinicallysignificant isolates per day demonstrating recommended days of incubati on (Bourbeau and Foltzer , 2005).
  • 21.
    PROCESSING POSITIVE BLOODCULTURES STAINING METHODS • Gram stain • Acridien orange IDENTIFICATION • subculture • Molecular testing • Mass spectrometry MALDI-TOF MS), DIRECT IDENTIFICATION • Accelerate phenotest BC kit • BD phoenix and biome ́rieux VITEK2 systems • Rapid AST (RAST) method based on direct disk diffusion (ddd) testing • Enzyme-based targeted AST (Singer et al., 2016).
  • 22.
    CLINICAL EVIDENCE OFBACTERIAL INFECTION IS PRESENT features of SSTI, urosepsis, pneumonia, SIRS criteria). Detection of the same pathogen in blood culture sets from different venipuncture sites Pathogens that rarely indicate contamination: oS. aureus oS. pneumoniae oS. pyogenes oEnterobacteriaceae spp. including E. coli oH. influenzae oP. aeruginosa oCandida spp oListeria monocytogenes oNeisseria meningitidis oAnaerobic Gram-negative rods (Doern et al., 2019).
  • 23.
    Figure: bacteria andyeast cells (Hall and Lyman, 2006).
  • 24.
    CONTAMINANT OR ATRUE PATHOGEN? A false positive is defined as growth of bacteria in the blood culture bottle that were not present in the patient’s bloodstream, and were most likely introduced during sample collection. Contamination can come from a number of sources: The patient’s skin, The equipment used to take the sample, The hands of the person taking the blood sample, or The environment. Certain microorganisms such as coagulase-negative staphylococci, viridans- group streptococci, Bacillus spp, Propionibacterium spp., diphtheroids, Micrococcus spp. rarely cause severe bacterial infections or bloodstream infections. These are common skin contaminants (Hall and Lyman, 2006).
  • 25.
    NEGATIVE BLOOD CULTURE Beforeruling out bacteremia, consider the following steps: Determine whether it is likely the result could be a false-negative Consider if: Collection performed during current antibiotic treatment Insufficient inoculation  volume of each blood culture Prolonged transportation time Assess whether the pathogen identified is a plausible cause of the presenting infection.If necessary, arrange for new blood culture sampling and analysis (Doern et al., 2019).
  • 26.
    CONCLUSION Blood cultures allowthe identification of pathogens, such as bacteria and fungi, in blood and their specific resistance testing. Knowing the pathogen enables effective, individualized antibiotic treatment, which reduces mortality, improves prognosis, minimizes the length of hospital stays, and reduces the growing number of antibiotic- resistant pathogens
  • 27.
    REFERENCES  Baron EJ,Weinstein MP, Dunne Jr. WM, Yagupsky P, Welch DF, Wilson DM. Cumitech 1C, Blood Cultures IV. Coordinating ed., E.J. Baron. ASM Press, Washington D.C. 2005. Bourbeau PP, Foltzer M. Routine incubation of BACT/ALERT* FA and FN blood culture bottles for more than 3 days may not be necessary. J Clin Microbiol. 2005;43:2506-250 Doern GV, Carroll KC, Diekema DJ, et al. A comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. Clin Microbiol Rev 2019;33(1). e00009-19 Doern GV, Carroll KC, Diekema DJ, et al. Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem. Clin Microbiol Rev. 2019; 33 (1). doi: 10.1128/cmr.00009-19 Gonzalez, M. D., Chao, T., & Pettengill, M. A. (2020). Modern Blood Culture. Clinics in Laboratory Medicine. doi:10.1016/j.cll.2020.07.001 Hall KK, Lyman JA. Updated Review of Blood Culture Contamination. Clin Microbiol Rev. 2006,19(4):788.
  • 28.
    REFERENCES https://www.slideshare.net/MostafaMahmoud76/manual-blood-culture-techniques Kellog JA, ManzellaJP, Bankert DA. Frequency of low-level bacteremia in children from birth to fifteen years of age.J Clin Microbiol. 2000;38:2181-2185. Ombelet S, Barbé B, Affolabi D, Ronat J-B, Lompo P, Lunguya O, Jacobs J and Hardy L (2019) Best Practices of Blood Cultures in Lowand Middle-Income Countries. Front. Med. 6:131. doi: 10.3389/fmed.2019.00131 Principles and procedures for Blood Cultures; Approved Guideline, CLSI document M47-A. Clinical and Laboratory Standards Institute (CLSI); Wayne, P.A. 2007 Singer M, Deutschmann CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. Singer M, Deutschmann CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
  • 29.

Editor's Notes

  • #7 (Ombelet et al., 2019
  • #10  A blood culture medium must be: sensitive enough to recover: -a broad range of clinically relevant microorganisms, even the most fastidious (Neisseria, Haemophilus.) -microorganisms releasing small amounts of CO2 (Brucella, Acinetobacter) versatile: able to provide a result for all types of sample collection (adults, infants, patients receiving antibiotic therapy, sterile body fluids...)
  • #11 Most modern media formulations are similar, a base of soybean casein digest (trypticase soy broth) with sodium polyanethol sulfonate (SPS) as an anticoagulant. The headspace of the bottles consists of CO2 and N2 for anaerobic bottles and ambient air supplemented with CO2 for aerobic bottles. Anaerobic bottles also include reducing agents. Resins can neutralize select antibacterial agents (including common empirically utilized antibiotics such as piperacillintazobactam, vancomycin, and some cephalosporins), but have lower to no ability to neutralize other agents (eg, carbapenems and fluoroquinolones).
  • #12 Contamination of blood cultures has a big impact on patient care and hospital resources. Several key factors that can reduce contamination rates have been clearly demonstrated. Skin sites for collection should be disinfected with an alcoholcontaining disinfectant, and blood should not be collected from an intravascular device unless specifically requested out of concern it is the source of bacteremia   the use of commercial diversion devices reduced contamination rates, which in models is projected to lead to considerable cost savings and reductions in patient length of stay   Because of the cost of diversion devices We can do this by diverting a small amount of blood using vacutainer tubes by changing the test draw order, which could also be accomplished for blood cultures alone by simply discarding the diverted portion.
  • #14 For an adult, the recommended volume of blood to be obtained per culture is 20 to 30 ml. 16   Note: This volume is recommended to optimize pathogen recovery when the bacterial/fungal burden is less than 1 Colony Forming Unit (CFU) per ml of blood, which is a common finding  
  • #17 Three US Food and Drug Administration (FDA)-cleared CMBCS are avail- able, including BACTEC (Becton-Dickinson, Sparks, MD, USA), BacT/Alert (bio- Me ́ rieux, Inc., Durham, North Carolina) and VersaTREK (Thermo Scientific, Waltham, Massachusetts).
  • #19 Three US Food and Drug Administration (FDA)-cleared CMBCS are avail- able, including BACTEC (Becton-Dickinson, Sparks, MD, USA), BacT/Alert (bio- Me ́ rieux, Inc., Durham, North Carolina) and VersaTREK (Thermo Scientific, Waltham, Massachusetts).
  • #20 Note: However, published data suggest that three days may be adequate to recover over 97% of clinically significant microorganisms.    
  • #21 Note: Blood cultures are routinely incubated for 4 to 7 days with CMBCS. Studies indicate that 98% to 99% of true pathogens are detected within 5 days of incubation relative to longer incubation times However, published data suggest that three days may be adequate to recover over 97% of clinically significant microorganisms.    
  • #22 Some microorganisms stain poorly or not all with Gram reagents, and for positive blood cultures with negative Gram stains there are alternative stains, such as acridine orange, which can be employed in addition to repeating Gram stains.
  • #23 Note: However, published data suggest that three days may be adequate to recover over 97% of clinically significant microorganisms.    
  • #24 Note: However, published data suggest that three days may be adequate to recover over 97% of clinically significant microorganisms.    
  • #25 It is unlikely that the detected pathogen  is the cause of the presenting infection (e.g., presence of skin microbiota  such as Corynebacteria  and Propionibacteria). Pathogens that likely indicate contamination:  Corynebacterium  spp. Bacillus spp. (except B. anthracis ) Others: Micrococcus spp., Cutibacterium acnes Most coagulase-negative staphylococci   Pathogens that may indicate contamination: Enterococci S. viridans Clostridium  spp. Blood culture sets were collected from an indwelling catheter. Detection of the same pathogen  in the blood culture set in the peripheral vein and in the catheter Marked differential time to positivity Bacterial detection was only successful in one blood culture bottle.
  • #26 It is unlikely that the detected pathogen  is the cause of the presenting infection (e.g., presence of skin microbiota  such as Corynebacteria  and Propionibacteria). Pathogens that likely indicate contamination:  Corynebacterium  spp. Bacillus spp. (except B. anthracis ) Others: Micrococcus spp., Cutibacterium acnes Most coagulase-negative staphylococci   Pathogens that may indicate contamination: Enterococci S. viridans Clostridium  spp. Blood culture sets were collected from an indwelling catheter. Detection of the same pathogen  in the blood culture set in the peripheral vein and in the catheter Marked differential time to positivity Bacterial detection was only successful in one blood culture bottle.